Core Scientific, Inc.
CORZQ
OTC PK
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -44.79% | -10.35% | |||
| Total Other Revenue | 17.26% | -38.47% | |||
| Total Revenue | -0.45% | -32.42% | |||
| Cost of Revenue | -5.31% | -8.58% | |||
| Gross Profit | 93.76% | -88.84% | |||
| SG&A Expenses | 1.26% | 31.06% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | 290.78% | -81.66% | |||
| Total Operating Expenses | -1.11% | 0.94% | |||
| Operating Income | 2.64% | -745.06% | |||
| Income Before Tax | 41.74% | 43.45% | |||
| Income Tax Expenses | 179.85% | -6.94% | |||
| Earnings from Continuing Operations | 41.67% | 43.44% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 41.67% | 43.44% | |||
| EBIT | 2.64% | -745.06% | |||
| EBITDA | -13.10% | -133.58% | |||
| EPS Basic | 48.59% | 73.96% | |||
| Normalized Basic EPS | 43.39% | 65.55% | |||
| EPS Diluted | 48.59% | 73.96% | |||
| Normalized Diluted EPS | 43.39% | 65.55% | |||
| Average Basic Shares Outstanding | 4.67% | 63.85% | |||
| Average Diluted Shares Outstanding | 4.67% | 63.85% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
